API HOLDINGS (PHARMEASY)

PharmEasy – India’s Leading Online Pharmacy & Digital Healthcare Platform

PharmEasy is one of India’s largest digital healthcare platforms, offering online medicine delivery, diagnostics booking, teleconsultation, and wellness products across thousands of pin codes. Founded in 2015, the company has transformed the way Indians access affordable healthcare services from the comfort of their homes.

As interest in healthtech investments grows, many investors actively track the PharmEasy unlisted share price, company valuation, and future IPO potential.

About PharmEasy

Founded by Dharmil Sheth and Dr. Dhaval Shah, PharmEasy operates under its parent company API Holdings.

The company connects:

Customers

Retail pharmacies

Diagnostic labs

Healthcare providers

Through its technology-driven marketplace model, PharmEasy simplifies healthcare delivery while improving accessibility and affordability.

Key Services Offered by PharmEasy 1. Online Medicine Delivery

Users can upload prescriptions and order medicines through the app or website with doorstep delivery.

2. Diagnostic & Lab Test Booking

PharmEasy partners with leading diagnostic networks including Thyrocare, enabling home sample collection and health checkups.

3. Teleconsultation

Patients can consult certified doctors online for medical advice and prescriptions.

4. Healthcare & Wellness Products

Wide range of OTC products, supplements, devices, and personal care items.

PharmEasy Business Model

PharmEasy follows a marketplace + inventory hybrid model, generating revenue through:

Commission from partner pharmacies

Sale of medicines and healthcare products

Diagnostic test bookings

Platform service fees

Advertising & brand promotions

The company leverages logistics, technology, and strategic acquisitions to expand margins and improve supply chain efficiency.

PharmEasy Share Price (Unlisted)

Since PharmEasy is not currently listed on NSE or BSE, its shares are traded in the unlisted/pre-IPO market.

Investors track:

Latest unlisted share price

Company valuation trends

Fundraising rounds

IPO announcements

Financial performance

⚠️ Note: Unlisted share prices fluctuate based on demand, supply, and company developments.

PharmEasy Financial Highlights (Overview)

Rapid revenue growth during expansion years

Operational restructuring to reduce burn

Debt restructuring and funding rounds

Focus on profitability improvement

The company has undergone valuation corrections in recent years, making it a closely watched healthtech investment opportunity.

PharmEasy IPO Status

PharmEasy had previously filed draft IPO papers but delayed listing due to market conditions. Investors continue to monitor updates regarding a potential future IPO launch.

If listed in the future, it could become one of India’s major healthtech IPOs.

Why Investors Track PharmEasy Shares?

Strong brand recall in online pharmacy

Large healthcare market opportunity

Expansion into diagnostics

Technology-led healthcare ecosystem

Potential IPO upside

However, investors should also evaluate risks including competition, regulatory changes, and profitability challenges.

Frequently Asked Questions (FAQs) Is PharmEasy listed on NSE or BSE?

No, PharmEasy is currently an unlisted company.

How can I buy PharmEasy unlisted shares?

You can buy PharmEasy shares through registered intermediaries dealing in pre-IPO/unlisted shares.

What is the minimum investment required?

Minimum investment varies depending on lot size and market availability.

Is PharmEasy planning an IPO?

The company has shown IPO intentions in the past. Investors should track official announcements for updates.